Kousik Kundu

Kousik Kundu

Auto-generated profile, based on publicly available information

Kousik Kundu

Wellcome Sanger Institute

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Cell
Verified
Journal Article
Open access
WAWilliam J. Astle
William J. Astle
HEHeather Elding
Heather Elding
TJTao Jiang
Tao Jiang
DADave Allen
Dave Allen
DRDace Ruklisa
Dace Ruklisa
NSNicole Soranzo
Nicole Soranzo
Many common variants have been associated with hematological traits, but identification of causal genes and pathways has proven challenging. We performed a genome-wide association analysis in the UK Biobank and INTERVAL studies, testing 29.5 million genetic variants for association with 36 red cell, white cell, and platelet properties in 173,480 European-ancestry participants. This effort yielded hundreds of low frequency (<5%) and rare (<1%) variants with a strong impact on blood cell phenotypes. Our data highlight general properties of the allelic architecture of complex traits, including the proportion of the heritable component of each blood trait explained by the polygenic signal across different genome regulatory domains. Finally, through Mendelian randomization, we provide evidence of shared genetic pathways linking blood cell indices with complex pathologies, including autoimmune diseases, schizophrenia, and coronary heart disease and evidence suggesting previously reported population associations between blood cell indices and cardiovascular disease may be non-causal.

1 November 2016 in Cell
Verified
Journal Article
Open access
LCLu Chen
Lu Chen
BGBing Ge
Bing Ge
FCFrancesco Paolo Casale
Francesco Paolo Casale
LVLouella Vasquez
Louella Vasquez
TKTony Kwan
Tony Kwan
NSNicole Soranzo
Nicole Soranzo
Characterizing the multifaceted contribution of genetic and epigenetic factors to disease phenotypes is a major challenge in human genetics and medicine. We carried out high-resolution genetic, epigenetic, and transcriptomic profiling in three major human immune cell types (CD14+ monocytes, CD16+ neutrophils, and naive CD4+ T cells) from up to 197 individuals. We assess, quantitatively, the relative contribution of cis-genetic and epigenetic factors to transcription and evaluate their impact as potential sources of confounding in epigenome-wide association studies. Further, we characterize highly coordinated genetic effects on gene expression, methylation, and histone variation through quantitative trait locus (QTL) mapping and allele-specific (AS) analyses. Finally, we demonstrate colocalization of molecular trait QTLs at 345 unique immune disease loci. This expansive, high-resolution atlas of multi-omics changes yields insights into cell-type-specific correlation between diverse genomic inputs, more generalizable correlations between these inputs, and defines molecular events that may underpin complex disease risk.

29 January 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HCHIPSCI Consortium
HIPSCI Consortium
KAKaur Alasoo
Kaur Alasoo
JRJulia Rodrigues
Julia Rodrigues
SMSubhankar Mukhopadhyay
Subhankar Mukhopadhyay
AKAndrew J. Knights
Andrew J. Knights
DGDaniel J. Gaffney
Daniel J. Gaffney

3 June 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AYAdam M H Young
Adam M H Young
NKNatsuhiko Kumasaka
Natsuhiko Kumasaka
FCFiona Calvert
Fiona Calvert
THTimothy R Hammond
Timothy R Hammond
AKAndrew Knights
Andrew Knights
DGDaniel J Gaffney
Daniel J Gaffney

23 August 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
NCNa Cai
Na Cai
AGAurora Gomez-Duran
Aurora Gomez-Duran
EYEkaterina Yonova-Doing
Ekaterina Yonova-Doing
KKKousik Kundu
Kousik Kundu
ABAnnette I. Burgess
Annette I. Burgess
NSNicole Soranzo
Nicole Soranzo

17 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BMBidesh Mahata
Bidesh Mahata
JPJhuma Pramanik
Jhuma Pramanik
LWLouise van der Weyden
Louise van der Weyden
KPKrzysztof Polanski
Krzysztof Polanski
GKGozde Kar
Gozde Kar
STSarah A. Teichmann
Sarah A. Teichmann
Tumors subvert immune cell function to evade immune responses, yet the complex mechanisms driving immune evasion remain poorly understood. Here we show that tumors induce de novo steroidogenesis in T lymphocytes to evade anti-tumor immunity. Using a transgenic steroidogenesis-reporter mouse line we identify and characterize de novo steroidogenic immune cells, defining the global gene expression identity of these steroid-producing immune cells and gene regulatory networks by using single-cell transcriptomics. Genetic ablation of T cell steroidogenesis restricts primary tumor growth and metastatic dissemination in mouse models. Steroidogenic T cells dysregulate anti-tumor immunity, and inhibition of the steroidogenesis pathway is sufficient to restore anti-tumor immunity. This study demonstrates T cell de novo steroidogenesis as a mechanism of anti-tumor immunosuppression and a potential druggable target.